Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04115241 · ClinicalTrials.gov registry record

Activity Levels in Bone Marrow Transplant Patients

A clinical trial of Bone Marrow Transplant, sponsored by Michael Tomasson.

Recruiting
Registry status
200
Enrollment target
1
Study location

NCT04115241: Recruiting study of Bone Marrow Transplant, sponsored by Michael Tomasson.

NCT04115241 is a study of Bone Marrow Transplant that is actively recruiting participants, run by Michael Tomasson. The registered enrollment target is 200 participants, above the 146-participant average among 4 other Bone Marrow Transplant trials with a reported enrollment target (37% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04115241, a study of Bone Marrow Transplant, is actively recruiting participants, sponsored by Michael Tomasson.

RECRUITING
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

Participants in this study will be receiving a bone marrow transplant. This study is designed to evaluate correlations between activity levels and length of stay, quality of life, and hand grip strength.

Primary Outcome

Participants will be given actigraphs to wear around their waists starting 3 weeks prior to bone marrow transplants until they are discharged from the hospital. Activity prior to and during hospitalization will be correlated with length of stay.

Conditions Studied

Interventions

  • DEVICE Actigraph
  • OTHER Grip strength test

Study Locations (1)

Iowa

  • University of Iowa - Iowa City

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2019-05-23
Est. Completion 2030-05-23
Michael Tomasson

2 total trials

What NCT04115241 shows while recruiting

NCT04115241 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 146-participant average among 4 other Bone Marrow Transplant trials with a reported enrollment target (37% higher).

The record links to 1 condition, with Bone Marrow Transplant appearing as the primary indexed condition, and to 2 interventions - of which Actigraph is the first listed.

NCT04115241 reports a single indexed study location in Iowa.

Frequently Asked Questions

What is clinical trial NCT04115241 about?

NCT04115241 is a clinical study titled "Activity Levels in Bone Marrow Transplant Patients". Participants in this study will be receiving a bone marrow transplant. This study is designed to evaluate correlations between activity levels and length of stay, quality of life, and hand grip strength.

What is the current status of trial NCT04115241?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2019-05-23. Estimated completion is 2030-05-23.

What conditions does trial NCT04115241 study?

This clinical trial studies the following conditions: Bone Marrow Transplant.

What interventions are being tested in trial NCT04115241?

The interventions under investigation include: Actigraph (DEVICE), Grip strength test (OTHER).

Who is sponsoring clinical trial NCT04115241?

This trial is sponsored by Michael Tomasson, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04115241 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bone Marrow Transplant

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04115241, the US trial registry maintained by the National Library of Medicine. NCT04115241 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.